BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22895089)

  • 1. Clustering of sialylated glycosylphosphatidylinositol anchors mediates PrP-induced activation of cytoplasmic phospholipase A 2 and synapse damage.
    Bate C; Williams A
    Prion; 2012; 6(4):350-3. PubMed ID: 22895089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodegeneration induced by clustering of sialylated glycosylphosphatidylinositols of prion proteins.
    Bate C; Williams A
    J Biol Chem; 2012 Mar; 287(11):7935-44. PubMed ID: 22262833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation.
    Bate C; Nolan W; Williams A
    J Biol Chem; 2016 Jan; 291(1):160-70. PubMed ID: 26553874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the tail wag the dog? How the structure of a glycosylphosphatidylinositol anchor affects prion formation.
    Bate C; Nolan W; Williams A
    Prion; 2016 Mar; 10(2):127-30. PubMed ID: 26901126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation.
    Bate C; Williams A
    J Biol Chem; 2011 Mar; 286(11):8752-8. PubMed ID: 21212283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-β-induced synapse damage is mediated via cross-linkage of cellular prion proteins.
    Bate C; Williams A
    J Biol Chem; 2011 Nov; 286(44):37955-37963. PubMed ID: 21900234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular prion protein with a monoacylated glycosylphosphatidylinositol anchor modifies cell membranes, inhibits cell signaling and reduces prion formation.
    Bate C; Williams A
    Prion; 2011; 5(2):65-8. PubMed ID: 21738009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylphosphatidylinositol anchor analogues sequester cholesterol and reduce prion formation.
    Bate C; Tayebi M; Williams A
    J Biol Chem; 2010 Jul; 285(29):22017-26. PubMed ID: 20427265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A glycosylphosphatidylinositol analogue reduced prion-derived peptide mediated activation of cytoplasmic phospholipase A2, synapse degeneration and neuronal death.
    Bate C; Tayebi M; Williams A
    Neuropharmacology; 2010; 59(1-2):93-9. PubMed ID: 20398681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialylated glycosylphosphatidylinositols suppress the production of toxic amyloid-β oligomers.
    Nolan W; McHale-Owen H; Bate C
    Biochem J; 2017 Aug; 474(17):3045-3058. PubMed ID: 28729427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α2,3 linkage of sialic acid to a GPI anchor and an unpredicted GPI attachment site in human prion protein.
    Kobayashi A; Hirata T; Nishikaze T; Ninomiya A; Maki Y; Takada Y; Kitamoto T; Kinoshita T
    J Biol Chem; 2020 May; 295(22):7789-7798. PubMed ID: 32321762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialic Acid within the Glycosylphosphatidylinositol Anchor Targets the Cellular Prion Protein to Synapses.
    Bate C; Nolan W; McHale-Owen H; Williams A
    J Biol Chem; 2016 Aug; 291(33):17093-101. PubMed ID: 27325697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines.
    Bate C; Tayebi M; Diomede L; Salmona M; Williams A
    PLoS One; 2009 Dec; 4(12):e8221. PubMed ID: 20011040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures.
    Bate C; Williams A
    Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prion protein and lipid rafts.
    Taylor DR; Hooper NM
    Mol Membr Biol; 2006; 23(1):89-99. PubMed ID: 16611584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
    Taylor DR; Whitehouse IJ; Hooper NM
    PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylphosphatidylinositols: More than just an anchor?
    Bate C; Nolan W; Williams A
    Commun Integr Biol; 2016; 9(2):e1149671. PubMed ID: 27195066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glimepiride protects neurons against amyloid-β-induced synapse damage.
    Osborne C; West E; Nolan W; McHale-Owen H; Williams A; Bate C
    Neuropharmacology; 2016 Feb; 101():225-36. PubMed ID: 26432105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurometals in the Pathogenesis of Prion Diseases.
    Kawahara M; Kato-Negishi M; Tanaka KI
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.